Alving B M, Baldwin P E, Richards R L, Jackson B J
Thromb Haemost. 1985 Oct 30;54(3):709-12.
A simple sensitive method for verification of lupus anticoagulants utilizing dilution of phospholipid in the activated partial thromboplastin time (APTT) system is described. Patient plasma, mixed with an equal volume of normal plasma, is activated with micronized silica. To this mixture are added different dilutions of Thrombofax and then calcium chloride. Clotting times are plotted linearly against the logarithm of the phospholipid dilutions and slopes are calculated by regression analysis. In this assay the mean negative slope of 19 plasmas that contained anti-phospholipid activity was five times greater than those of normal plasma or those obtained from patients having single or multiple coagulation factor deficiencies such as those induced by warfarin. The assay can be modified to test heparinized plasmas. Thus, it is a sensitive means by which to verify the presence of lupus anticoagulants in patients who have congenital or acquired factor deficiencies or who are receiving anticoagulant therapy.
描述了一种利用活化部分凝血活酶时间(APTT)系统中磷脂稀释来验证狼疮抗凝物的简单灵敏方法。将患者血浆与等体积的正常血浆混合,用微粉化硅胶激活。向该混合物中加入不同稀释度的凝血因子,然后加入氯化钙。将凝血时间与磷脂稀释度的对数进行线性作图,并通过回归分析计算斜率。在该检测中,19份含有抗磷脂活性的血浆的平均负斜率比正常血浆或由华法林等诱导的单一或多种凝血因子缺乏患者的血浆的负斜率大五倍。该检测方法可进行修改以检测肝素化血浆。因此,它是一种灵敏的方法,可用于验证先天性或获得性因子缺乏患者或正在接受抗凝治疗患者中狼疮抗凝物的存在。